FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, and concerns an injectable insulin preparation for reducing an individual's blood glucose level. The preparation contains an insulin compound, a nicotinic acid compound and arginine.
EFFECT: invention provides the fast absorption of the insulin compound, a possibility to administer the preparation closer to a meal, as well as reduces a risk of hypoglycemia following meals.
14 cl, 5 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INSULIN DERIVATIVES CONTAINING ADDITIONAL DISULFIDE BONDS | 2011 |
|
RU2598273C2 |
| NOVEL INSULIN DERIVATIVES AND USE THEREOF | 2015 |
|
RU2684456C2 |
| PROTEASE-RESISTANT INSULIN ANALOGUES | 2007 |
|
RU2524150C2 |
| INSULIN PURIFICATION | 2012 |
|
RU2603752C2 |
| STABLE NON-AQUEOUS PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2472492C2 |
| ACYLATED INSULIN ANALOGUES STABILISED WITH RESPECT TO PROTEASES | 2009 |
|
RU2571857C2 |
| INSULIN PREPARATION CONTAINING NACL, PARENTERAL FINISHED FORM, METHOD FOR INCREASING CHEMICAL STABILITY OF INSULIN PREPARATION | 1997 |
|
RU2182015C2 |
| NOVEL DERIVATIVE OF INSULIN ANALOGUE | 2014 |
|
RU2673185C2 |
| PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2670106C2 |
| INSULIN DERIVATIVE, SOLUBLE PROLONGED PHARMACEUTICAL COMPOSITION, METHOD OF PROLONGATION OF HYPOGLYCAEMIC EFFECT IN TREATMENT OF DIABETIC PATIENTS | 1994 |
|
RU2164520C2 |
